{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:39:05Z","timestamp":1782351545974,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T00:00:00Z","timestamp":1460505600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10067-016-3263-4","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:15:45Z","timestamp":1460625345000},"page":"1437-1441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["IL-23\/IL-17 axis in spondyloarthritis-bench to bedside"],"prefix":"10.1007","volume":"35","author":[{"given":"Siba P.","family":"Raychaudhuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti K.","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,13]]},"reference":[{"issue":"9","key":"3263_CR1","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0198-8859(03)00162-9","volume":"64","author":"DD Gladman","year":"2003","unstructured":"Gladman DD, Farwell VT, Pellett F, Schentag C, Raham P (2003) HLA is a candidate region for psoriatic arthritis. Evidence for excessive HLA sharing in sibling pairs. Hum Immunol 64(9):887\u2013889","journal-title":"Hum Immunol"},{"issue":"2","key":"3263_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","volume":"12","author":"MA Brown","year":"2016","unstructured":"Brown MA, Kenna T, Wordsworth BP (2016) Genetics of ankylosing spondylitis-insights into pathogenesis. Nat Rev Rheumatol 12(2):81\u201391","journal-title":"Nat Rev Rheumatol"},{"issue":"1\u20132","key":"3263_CR3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11010-011-1036-6","volume":"359","author":"SP Raychaudhuri","year":"2012","unstructured":"Raychaudhuri SP, Raychaudhuri SK, Genovese MC (2012) IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem 359(1\u20132):419\u2013429","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"3263_CR4","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10067-015-2961-7","volume":"34","author":"SK Raychaudhuri","year":"2015","unstructured":"Raychaudhuri SK, Saxena A, Raychaudhuri SP (2015) Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis. Clin Rheumatol 34(6):1019\u20131023","journal-title":"Clin Rheumatol"},{"key":"3263_CR5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semarthrit.2013.04.006","volume":"43","author":"WB Berg van den","year":"2013","unstructured":"van den Berg WB, McInnes IB (2013) Th17 cells and IL-17 a\u2014focus on immunopathogenesis and immunotherapeutics. Semin Arthritis Rheum 43:158\u2013170","journal-title":"Semin Arthritis Rheum"},{"key":"3263_CR6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","volume":"31","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Korn T, Kuchroo VK, Anderson AC (2008) Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 31:252\u2013256","journal-title":"J Autoimmun"},{"key":"3263_CR7","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT (2005) Interleukin 17-producing CD4 effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123\u20131132","journal-title":"Nat Immunol"},{"key":"3263_CR8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor ROR \u03bbt directs the differentiation program of proinflammatory IL-17-T helper cells. Cell 126:1121\u20131133","journal-title":"Cell"},{"key":"3263_CR9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","volume":"361","author":"P Miossec","year":"2009","unstructured":"Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361:888\u2013898","journal-title":"N Engl J Med"},{"key":"3263_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/intimm\/dxr001","volume":"23","author":"LA Zenewicz","year":"2011","unstructured":"Zenewicz LA, Flavell RA (2011) Recent advances in IL-22 biology. Int Immunol 23:159\u2013163","journal-title":"Int Immunol"},{"key":"3263_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00628.x","volume":"223","author":"LA Tesmer","year":"2008","unstructured":"Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87\u2013113","journal-title":"Immunol Rev"},{"issue":"8","key":"3263_CR12","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.4049\/jimmunol.179.8.5462","volume":"179","author":"RE Kuestner","year":"2007","unstructured":"Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K et al (2007) Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol 179(8):5462\u20135473","journal-title":"J Immunol"},{"issue":"11","key":"3263_CR13","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.4049\/jimmunol.179.11.7791","volume":"179","author":"SC Liang","year":"2007","unstructured":"Liang SC, Long AJ, Bennett F, Whitters MJ, Karim R, Collins M et al (2007) An IL-17F\/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 179(11):7791\u20137799","journal-title":"J Immunol"},{"issue":"19","key":"3263_CR14","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1093\/emboj\/20.19.5332","volume":"20","author":"SG Hymowitz","year":"2001","unstructured":"Hymowitz SG, Filvaroff EH, Yin J, Lee J, Cai L, Risser P et al (2001) IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J 20(19):5332\u20135341","journal-title":"EMBO J"},{"issue":"11","key":"3263_CR15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1006\/cyto.1997.0240","volume":"9","author":"Z Yao","year":"1997","unstructured":"Yao Z, Spriggs MK, Derry JM, Strockbine L, Park LS, Vanden Bos T et al (1997) Molecular characterization of the human interleukin (IL)-17 receptor. Cytokine 9(11):794\u2013800","journal-title":"Cytokine"},{"issue":"12","key":"3263_CR16","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ni.1813","volume":"10","author":"LK Ely","year":"2009","unstructured":"Ely LK, Fischer S, Garcia KC (2009) Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 10(12):1245\u20131251","journal-title":"Nat Immunol"},{"issue":"2","key":"3263_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/BOR.0000000000000147","volume":"27","author":"PJ Mease","year":"2015","unstructured":"Mease PJ (2015) Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis. Curr Opin Rheumatol 27(2):127\u2013133","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3263_CR18","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2013.07.013","volume":"57","author":"RA Colbert","year":"2014","unstructured":"Colbert RA, Tran TM, Layh-Schmitt G (2014) HLA-B27 misfolding and ankylosing spondylitis. Mol Immunol 57(1):44\u201351","journal-title":"Mol Immunol"},{"issue":"2","key":"3263_CR19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","volume":"42","author":"JD Reveille","year":"2010","unstructured":"Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ et al (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42(2):123\u2013127","journal-title":"Nat Genet"},{"key":"3263_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10067-010-1647-4","volume":"30","author":"Y Mei","year":"2011","unstructured":"Mei Y, Pan F, Gao J, Ge R, Duan Z, Zeng Z, Liao F, Xia G, Wang S, Xu S, Xu J, Zhang L, Ye D (2011) Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol 30:269\u2013273","journal-title":"Clin Rheumatol"},{"issue":"12","key":"3263_CR21","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/art.30593","volume":"63","author":"L Zeng","year":"2011","unstructured":"Zeng L, Lindstrom MJ, Smith JA (2011) Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide. Arthritis Rheum 63(12):3807\u20133817","journal-title":"Arthritis Rheum"},{"key":"3263_CR22","doi-asserted-by":"crossref","first-page":"R95","DOI":"10.1186\/ar3370","volume":"13","author":"H Appel","year":"2011","unstructured":"Appel H, Maier R, Wu P, Scheer R, Hempfing A, Kayser R, Thiel A, Radbruch A, Loddenkemper C, Sieper J (2011) Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response. Arthritis Res Ther 13:R95","journal-title":"Arthritis Res Ther"},{"key":"3263_CR23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10067-010-1646-5","volume":"30","author":"AK Singh","year":"2011","unstructured":"Singh AK, Misra R, Aggarwal A (2011) Th17 associated cytokines in patients with reactive arthritis\/undifferentiated spondylarthropathy. Clin Rheumatol 30:771\u2013776","journal-title":"Clin Rheumatol"},{"issue":"6924","key":"3263_CR24","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","volume":"421","author":"DJ Cua","year":"2003","unstructured":"Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421(6924):744\u2013748","journal-title":"Nature"},{"key":"3263_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP et al (2012) IL-23 induces spondyloarthropathy by acting on ROR-gammat\u00fe CD3\u00feCD4-CD8- entheseal resident T cells. Nat Med 18:1069\u20131076","journal-title":"Nat Med"},{"issue":"2","key":"3263_CR26","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar3781","volume":"14","author":"A Mitra","year":"2012","unstructured":"Mitra A, Raychaudhuri SK, Raychaudhuri SP (2012) Functional role of IL-22 in psoriatic arthritis. Arthritis Res Ther 14(2):R65","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3263_CR27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.rdc.2015.07.002","volume":"41","author":"DD O'Rielly","year":"2015","unstructured":"O'Rielly DD, Rahman P (2015) Genetic, epigenetic and pharmacogenetic aspects of psoriasis and psoriatic arthritis. Rheum Dis Clin N Am 41(4):623\u2013642","journal-title":"Rheum Dis Clin N Am"},{"issue":"8","key":"3263_CR28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nri2586","volume":"9","author":"SL Gaffen","year":"2009","unstructured":"Gaffen SL (2009) Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 9(8):556\u2013567","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"3263_CR29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-7682-1-19","volume":"1","author":"D Ge","year":"2008","unstructured":"Ge D, You Z (2008) Expression of interleukin-17RC protein in normal human tissues. Int Arch Med 1(1):19","journal-title":"Int Arch Med"},{"issue":"11","key":"3263_CR30","doi-asserted-by":"crossref","first-page":"6383","DOI":"10.4049\/jimmunol.161.11.6383","volume":"161","author":"P Schwarzenberger","year":"1998","unstructured":"Schwarzenberger P et al (1998) IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol 161(11):6383\u20136389","journal-title":"J Immunol"},{"issue":"1","key":"3263_CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1183\/09031936.04.00032904","volume":"25","author":"A Linden","year":"2005","unstructured":"Linden A, Laan M, Anderson GP (2005) Neutrophils, interleukin-17A and lung disease. Eur Respir J 25(1):159\u2013172","journal-title":"Eur Respir J"},{"issue":"6","key":"3263_CR32","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1084\/jem.183.6.2593","volume":"183","author":"F Fossiez","year":"1996","unstructured":"Fossiez F et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183(6):2593\u20132603","journal-title":"J Exp Med"},{"issue":"5","key":"3263_CR33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.30278","volume":"63","author":"A Saxena","year":"2011","unstructured":"Saxena A, Raychaudhuri SK, Raychaudhuri SP (2011) Interleukin-17-induced proliferation of fibroblast-like synovial cells is mTOR dependent. Arthritis Rheum 63(5):1465\u20131466","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3263_CR34","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood-2002-05-1461","volume":"101","author":"M Numasaki","year":"2003","unstructured":"Numasaki M, Fukushi J, Ono M et al (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101(7):2620\u20132627","journal-title":"Blood"},{"issue":"10","key":"3263_CR35","doi-asserted-by":"crossref","first-page":"e13416","DOI":"10.1371\/journal.pone.0013416","volume":"5","author":"ML Toh","year":"2010","unstructured":"Toh ML et al (2010) Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression. PLoS One 5(10):e13416","journal-title":"PLoS One"},{"issue":"6","key":"3263_CR36","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.179.6.4135","volume":"179","author":"J Hartupee","year":"2007","unstructured":"Hartupee J, Liu C, Novotny M, Li X, Hamilton T (2007) IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 179(6):4135\u20134141","journal-title":"J Immunol"},{"issue":"9","key":"3263_CR37","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.22060","volume":"54","author":"H Appel","year":"2006","unstructured":"Appel H, Kuhne M, Spiekermann S, Ebhardt H, Grozdanovic Z, K\u00f6hler D, Dreimann M, Hempfing A, Rudwaleit M, Stein H, Metz-Stavenhagen P, Sieper J, Loddenkemper C (2006) Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis. Arthritis Rheum 54(9):2845\u20132851","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3263_CR38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","volume":"111","author":"CT Ritchlin","year":"2003","unstructured":"Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM (2003) Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111(6):821\u2013831","journal-title":"J Clin Invest"},{"issue":"1","key":"3263_CR39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9440(10)62961-6","volume":"167","author":"MI Koenders","year":"2005","unstructured":"Koenders MI, Lubberts E, Oppers-Walgreen B, van den Bersselaar L, Helsen MM, Di Padova FE et al (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 167(1):141\u2013149","journal-title":"Am J Pathol"},{"issue":"9","key":"3263_CR40","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","volume":"103","author":"S Kotake","year":"1999","unstructured":"Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345\u20131352","journal-title":"J Clin Invest"},{"issue":"6","key":"3263_CR41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","volume":"74","author":"IE Adamopoulos","year":"2015","unstructured":"Adamopoulos IE, Suzuki E, Chao CC, Gorman D, Adda S, Maverakis E et al (2015) IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann Rheum Dis 74(6):1284\u20131292","journal-title":"Ann Rheum Dis"},{"key":"3263_CR42","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","volume":"371","author":"RG Langley","year":"2014","unstructured":"Langley RG, Elewski BE, Lebwohl M et al (2014) Secukinumab in plaque psoriasis\u2014results of two phase 3 trials. N Engl J Med 371:326\u2013338","journal-title":"N Engl J Med"},{"key":"3263_CR43","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1002\/art.38939","volume":"66","author":"PJMI Mease","year":"2014","unstructured":"Mease PJMI, Kirkham B, Kavanaugh A et al (2014) Secukinumab, a human anti\u2013interleukin-17A monoclonal antibody, improves active psoriatic arthritis and inhibits radiographic progression: efficacy and safety data from a phase 3 randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheumatol 66:3529\u20133540","journal-title":"Arthritis Rheumatol"},{"key":"3263_CR44","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(13)61134-4","volume":"382","author":"D Baeten","year":"2013","unstructured":"Baeten D, Baraliakos X, Braun J et al (2013) Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial. Lancet 382:1705\u20131713","journal-title":"Lancet"},{"key":"3263_CR45","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1056\/NEJMoa1109997","volume":"366","author":"C Leonardi","year":"2012","unstructured":"Leonardi C, Matheson R, Zachariae C et al (2012) Anti-interleukin-17monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med 366:1190\u20131199","journal-title":"N Engl J Med"},{"key":"3263_CR46","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(08)60726-6","volume":"371","author":"KA Papp","year":"2008","unstructured":"Papp KA, Langley RG, Lebwohl M et al (2008) Efficacy and safety of ustekinumab, a human interleukin- 12\/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675\u20131684","journal-title":"Lancet"},{"key":"3263_CR47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/annrheumdis-2013-204655","volume":"73","author":"C Ritchlin","year":"2014","unstructured":"Ritchlin C, Rahman P, Kavanaugh A et al (2014) Efficacy and safety of the anti-IL-12\/23 p40monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial. Ann Rheum Dis 73:990\u2013999","journal-title":"Ann Rheum Dis"},{"key":"3263_CR48","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2014.01.025","volume":"133","author":"H Sofen","year":"2014","unstructured":"Sofen H, Smith S, Matheson RT et al (2014) Guselkumab (an IL-23-specific mAb) demonstrates clinical andmolecular response in patients with moderate-to-severe psoriasis. J Allergy Clin Immunol 133:1032\u20131040","journal-title":"J Allergy Clin Immunol"},{"key":"3263_CR49","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature14175","volume":"521","author":"T Kopp","year":"2015","unstructured":"Kopp T, Riedl E, Bangert C et al (2015) Clinical improvement in psoriasis with specific targeting of interleukin-23. Nature 521:222\u2013226","journal-title":"Nature"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3263-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3263-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:47:37Z","timestamp":1692290857000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,13]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3263"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3263-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,13]]}}}